Antiviral treatment of cytomegalovirus infection: an update. - Wikidata - wikimedia - TriplyDB

Antiviral treatment of cytomegalovirus infection: an update.

Antiviral treatment of cytomegalovirus infection: an update.

http://www.wikidata.org/entity/Q43992958

about

Rationally designed chemokine-based toxin targeting the viral G protein-coupled receptor US28 potently inhibits cytomegalovirus infection in vivo.Antagonistic Relationship between Human Cytomegalovirus pUL27 and pUL97 Activities during Infection.Murine cytomegalovirus infection of mouse macrophages stimulates early expression of suppressor of cytokine signaling (SOCS)1 and SOCS3.In vitro drug combination studies of Letermovir (AIC246, MK-8228) with approved anti-human cytomegalovirus (HCMV) and anti-HIV compounds in inhibition of HCMV and HIV replication.Characterization of Cytomegalovirus Breakthrough Events in a Phase 2 Prophylaxis Trial of Letermovir (AIC246, MK 8228).Geno- and phenotypic characterization of human cytomegalovirus mutants selected in vitro after letermovir (AIC246) exposure.Changes in subcellular localization reveal interactions between human cytomegalovirus terminase subunits Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT.

P2860

Q35845907-60A4A430-0906-4491-BBEA-0E0B1F07294A Q36086320-6C2EB68D-C7CF-4064-9B5E-CCEEDEEC4D63 Q36275767-397D6510-2733-4EF6-AB0C-E0981A6F6744 Q38898723-37A34424-8FC0-4202-B010-3D178165EFB1 Q41138845-E524E46F-98C4-4F5F-B2B1-77339F6CE916 Q41907417-1805FD5F-DF9B-469C-8682-5677FC255E3A Q42777243-AF032527-7445-4953-B57B-94FC7390D678 Q47734612-7572A879-BD11-451B-BA49-F40CD4D3C292

P2860

Antiviral treatment of cytomegalovirus infection: an update.

http://www.wikidata.org/entity/Q43992958

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Antiviral treatment of cytomegalovirus infection: an update.

@en

Antiviral treatment of cytomegalovirus infection: an update.

@nl

type

label

Antiviral treatment of cytomegalovirus infection: an update.

@en

Antiviral treatment of cytomegalovirus infection: an update.

@nl

prefLabel

Antiviral treatment of cytomegalovirus infection: an update.

@en

Antiviral treatment of cytomegalovirus infection: an update.

@nl

P1433

Q43992958-51EE2E52-1718-42DC-B579-367BECA992FB

P1476

Q43992958-FFD8155B-A74D-4ABE-8F84-11F2CB085529

P2093

Q43992958-003A6AC4-6DB8-4C9B-BA20-36C7D3325E8D

Q43992958-D276A5E5-04D5-4942-84DB-40A3B8FC0758

P2860

Q43992958-0D0815FE-681A-4A63-A4DB-AEC54D9744B1

Q43992958-25274FC4-3AC7-407F-902D-AB6BBE71941B

Q43992958-3A68F8BF-075C-4DEE-94DD-D77B06CDE376

Q43992958-3F9B262E-57D8-41BB-AAD3-DC1D6D85565E

Q43992958-42839FEA-5AE5-427B-A067-082F5E0807D6

Q43992958-44849D6A-E08C-4BC7-8F1F-1DE06E6C0FD9

Q43992958-4D00D810-5BFE-48A4-845A-0A74B178ED82

Q43992958-521B2DB4-D01C-4DD4-81F0-E180C23727BD

Q43992958-5566359A-7570-4EB8-BFB8-9FC830096249

Q43992958-5F75CFC4-DC9E-489A-BF04-50DA576531D9

P304

Q43992958-3AC51306-4F22-4B1D-B62F-AA336B1CD1CE

P31

Q43992958-CD3F2402-1D39-4F76-8082-678D386614BC

Q43992958-d526c3b9-1b87-4695-96b8-c247ae169668

P356

Q43992958-D41132B1-00A5-4EE6-8360-8778D11F3C53

P407

Q43992958-5C04000C-15C3-499C-8B6A-18A2B29DE20F

P433

Q43992958-AAF9D38C-CCC3-4458-B614-DD68A594442E

P478

Q43992958-7807DFAC-11F8-499A-AB2A-1D2678D628F9

P577

Q43992958-E4AFE415-7FAD-4E6B-BB6D-CD552C415175

P5875

Q43992958-80ED0642-45F1-4642-9B8F-583BB05F61F1

P698

Q43992958-F25DD19A-6458-490E-87CC-629051CD3D78

P921

Q43992958-196A91BA-4445-462C-9C4C-3945C9D52E6D

P356

14656566.2012.658775

P1433

Expert Opinion on Pharmacotherapy

P1476

Antiviral treatment of cytomegalovirus infection: an update.

@en

P2093

Detlef Michel

http://www.w3.org/2001/XMLSchema#string

Georg Härter

http://www.w3.org/2001/XMLSchema#string

P2860

A new tool linking human cytomegalovirus drug resistance mutations to resistance phenotypes

Mass spectrometry-based comparative sequencing to detect ganciclovir resistance in the UL97 gene of human cytomegalovirus.

Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility.

Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation.

The biology of cytomegalovirus drug resistance

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation.

Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients.

Cytomegalovirus quantification: where to next in optimising patient management?

The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase.

In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246.

P304

623-627

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2012.658775

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221800549

http://www.w3.org/2001/XMLSchema#string

P698

22299626

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus